Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Yang Jay currently maintains 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This activity is concentrated under 1 distinct examiner and a distinct art unit, showing a specific prosecution footprint. This lack of distribution across different examiners suggests that the company's current active matters are likely confined to a particular pharmaceutical innovation.
VANHORN, ABIGAIL LOUISE is the busiest examiner, holding the busiest examiner pending office action. Because this examiner manages the entirety of the company's pending workload, the progression of the portfolio is subject to this individual's specific examination criteria. Understanding this examiner's approach to biotechnology claims will be critical for resolving the pending action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANHORN, ABIGAIL LOUISE | 1 | 46.8% | +22.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555113 | APTAMER-TYPE MULTI-WARHEAD COVALENT DRUG | VANHORN, ABIGAIL LOUISE | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18555113 | APTAMER-TYPE MULTI-WARHEAD COVALENT DRUG | VANHORN, ABIGAIL LOUISE | 1635 | §103DP | Non-Final OA | — | Pending | Oct 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialYang Jay has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Abigail Louise Vanhorn has the most, with 1 of Yang Jay's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
